Get flat Rs. 500 off on Spandan PRO prepaid orders only. Use coupon code PRO500 during checkout
The revolutionary portable ECG device
The revolutionary portable ECG device
The Next Generation Cardiac care
The Next Generation Cardiac care
12 Lead ECG Unleashed in a Cord
12 Lead ECG Unleashed in a Cord
Heart Health Monitor for Tough Terrains
Heart Health Monitor for Tough Terrains
Who we are, and what we aim to achieve
Who we are, and what we aim to achieve
our accomplishments and impact in the society
our accomplishments and impact in the society
Join our fox tribe and explore limitless opportunities
Join our fox tribe and explore limitless opportunities
List of Compatible smart phones
List of Compatible smart phones
Our Healthy Cardiac Health Digest
Our Healthy Cardiac Health Digest
Our Research and Publications
Our Research and Publications
Recognitions in the media
Recognitions in the media
Seamless cardiac diagnostics in Medical settings.
Seamless cardiac diagnostics in Medical settings.
Remote monitoring and early detection for patients
Remote monitoring and early detection for patients
Lorem ipsum dolor sit amet
Lorem ipsum dolor sit amet
Lorem ipsum dolor sit amet
Lorem ipsum dolor sit amet
A 30-year-old man under Dr. C.B. Pandey and LLRM Meerut’s cardiology team care was diagnosed with ventricular tachycardia (VT). Treatment with amiodarone restored normal sinus rhythm (NSR), but further tests, including a 2D-ECHO, revealed cardiac sarcoidosis, confirmed by elevated ACE levels.
Despite optimal care, the patient experienced recurrent VT episodes. He began using Spandan® ECG for continuous monitoring, which consistently detected VT episodes. One ECG report in particular showed Wide QRS indicative of VT (LBBB Type), displaying a monomorphic pattern.
Based on the Spandan® ECG data, the patient had an
Automatic Implantable Cardioverter-Defibrillator (AICD) implanted for ongoing cardiac management by the LLRM Meerut cardiology team led by Dr. C.B.Pandey.
Follow-up device reports displayed a normal ECG rhythm, affirming the efficacy of AICD implantation and ongoing monitoring in managing the patient’s cardiac condition.